Session II of the workshop was structured to provide an overview of ethical and legal issues related to data dissemination. Mary Ann Baily, Institute for Ethics, American Medical Association, presented a commissioned paper for the workshop entitled « Regulating Access to Research Data Files: Ethical Issues ». Donna Eden, Office of the General Counsel, U.S. Department of Health and Human Services, shared her assessment of recent and future legislative developments. Finally, Thomas Puglisi of the Office for Protection from Research Risks (OPRR), National Institutes of Health, provided an overview of the role of institutional research councils (IRBs). When it comes to obtaining permission to share personal data, the US and EU take different approaches. In the United States, the « opt-out » model is widespread; In this model, the standard agreement is that you have agreed to share your information with the organization and must explicitly tell them that you do not want to share your information. There is no law prohibiting the sharing of your information (beyond certain categories of data, such as medical records). In the European Union, the « opt-in » model is required as standard. In this case, you must give your explicit permission before an organization can share your information.
Just because something is legal or approved by an IRB does not mean it is ethical. The collection, sharing, and publication of Internet data created by or about individuals may result in unwanted public scrutiny, harm, and other negative consequences for those individuals. For these reasons, some researchers attempt to anonymize internet data before sharing it or publishing an article that specifically quotes a message. However, the anonymization of Internet data does not give Internet users recognition as creators and authors. The Health Insurance Portability and Accountability Act includes requirements for the disclosure of informed consent and standards for electronic exchange, confidentiality and security of information. In the UK, general legislation can be found in data protection law. [9] The basic concept of data ethics is that personal data belongs to individuals. It is illegal and unethical to acquire personal data from a person without their consent and authorization. Balancing relative benefits and costs – First, data stewards need to develop information about the benefits associated with research on the use of personal data and the harms that could result from granting access. This activity includes the study of the attitudes of the people concerned.
The benefits and costs can vary considerably in different contexts. The benefits must then be weighed against the costs to determine access policy, with advice and accountability to the community as a whole by democratic institutions. When clarifying the information and consent obligations of data controllers, it makes sense to think on three levels. There should be a basic level of education on the role of data and research in the proper functioning of society. The goal is to make people understand that information about them is collected and used, with guarantees of confidentiality, in a routine way, and that it is their civic responsibility to accept it in exchange for medical progress, an effective education system, the protection of their civil rights, etc. This level implies a category of « ordinary » research applications that provide significant social benefits with a low risk of harmful disclosure. For searches in this category, there is no obligation to inform data subjects of any use or to obtain explicit consent, although there should be a way for subjects to know what research is being conducted with the data if they wish. The ethical and legal issues surrounding the conduct of clinical research with human participants had been a concern for policymakers, lawyers, scientists and clinicians for many years. The Declaration of Helsinki established ethical principles for clinical research involving human participants.
The goal of clinical research is to systematically collect and analyze data from which potentially generalizable conclusions can be drawn in order to improve clinical practice and benefit patients in the future. Therefore, it is important to be familiar with Good Clinical Practice (GCP), an international quality standard provided by the International Conference on Harmonization of Technical Requirements for Registration of Human Pharmaceuticals (ICH)[1] or the local version, Central Drugs Standard Control Organization (India`s equivalent of the U.S. Food and Drug Administration)[2] and local regulatory policy, Ensure that research is conducted in an ethical and legal manner. In this article, we will briefly discuss the legal and ethical issues surrounding human recruitment, the basic principles of informed consent, and precautions to take when publishing data and clinical research. Some of the fundamental principles of PCM in research include defining the responsibilities of sponsors, researchers, monitoring and reviewing consent processes, and protecting individuals. [3] According to the ICH definition, « informed consent is a procedure by which a subject voluntarily confirms his or her willingness to take a particular examination after being informed of all aspects of the examination relevant to the subject`s decision to participate ».